Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AxoGen, Inc. (AXGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
11.16+0.93 (+9.09%)
At close: 04:00PM EDT
11.35 +0.19 (+1.70%)
After hours: 06:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close10.23
Open10.23
Bid8.25 x 800
Ask16.84 x 800
Day's Range10.10 - 11.22
52 Week Range6.87 - 17.99
Volume289,852
Avg. Volume251,203
Market Cap471.886M
Beta (5Y Monthly)0.82
PE Ratio (TTM)N/A
EPS (TTM)-0.77
Earnings DateNov 01, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJan 27, 2010
1y Target Est19.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AXGN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AxoGen, Inc.
    Analyst Report: Baxter International Inc.Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. The company offers contract manufacturing services to pharmaceutical companies. The Hillrom transaction has added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's 2021 revenue came from more digitally connected offerings like its smart beds and Voalte medical communications app.
    Rating
    Fair Value
    Economic Moat
    18 days agoMorningstar
View more
Advertisement
Advertisement